$ARWR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ARROWHEAD PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ARROWHEAD PHARMACEUTICALS, INC. for free.

Page: 1 2 3 4 5 ... 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 24 2021	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	89.21	4,500	401,445	114,868	119.4 K to 114.9 K (-3.77 %)
Feb 24 2021	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	88.73	1,125	99,821	13,875	15 K to 13.9 K (-7.50 %)
Feb 10 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Option Exercise	M	5.22	90,000	469,800	60,000
Feb 10 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	89.66	5,436	487,392	293,375	298.8 K to 293.4 K (-1.82 %)
Feb 10 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	88.88	45,348	4,030,530	298,811	344.2 K to 298.8 K (-13.18 %)
Feb 10 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	88.08	31,255	2,752,940	344,159	375.4 K to 344.2 K (-8.33 %)
Feb 10 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	86.72	7,961	690,378	375,414	383.4 K to 375.4 K (-2.08 %)
Feb 10 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Buy	M	5.22	90,000	469,800	383,375	293.4 K to 383.4 K (+30.68 %)
Jan 19 2021	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	83.28	3,000	249,840	12,500	15.5 K to 12.5 K (-19.35 %)
Jan 15 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	81.82	3,814	312,061	126,250	130.1 K to 126.3 K (-2.93 %)
Jan 15 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	80.97	6,186	500,880	130,064	136.3 K to 130.1 K (-4.54 %)
Jan 12 2021	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	81.00	1,441	116,721	444,005	445.4 K to 444 K (-0.32 %)
Jan 12 2021	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	81.02	11,597	939,589	445,446	457 K to 445.4 K (-2.54 %)
Jan 08 2021	ARWR	ARROWHEAD PHARMACE ...	Hassard James	Chief Commercial Of ...	Sell	S	75.00	15,625	1,171,875	109,375	125 K to 109.4 K (-12.50 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	72.67	13,243	962,369	293,375	306.6 K to 293.4 K (-4.32 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	72.27	10,615	767,146	306,618	317.2 K to 306.6 K (-3.35 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	O'Brien Patrick	General Counsel	Sell	S	70.78	1,142	80,831	317,233	318.4 K to 317.2 K (-0.36 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	72.63	25,166	1,827,807	457,043	482.2 K to 457 K (-5.22 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	71.77	4,359	312,845	482,209	486.6 K to 482.2 K (-0.90 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	70.75	1,100	77,825	486,568	487.7 K to 486.6 K (-0.23 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	72.67	14,708	1,068,830	136,250	151 K to 136.3 K (-9.74 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	72.05	3,967	285,822	150,958	154.9 K to 151 K (-2.56 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	70.89	700	49,623	154,925	155.6 K to 154.9 K (-0.45 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	73.93	1,925	142,315	155,625	157.6 K to 155.6 K (-1.22 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	72.91	10,350	754,619	157,550	167.9 K to 157.6 K (-6.16 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	72.19	3,300	238,227	167,900	171.2 K to 167.9 K (-1.93 %)
Jan 07 2021	ARWR	ARROWHEAD PHARMACE ...	Hamilton James C		Sell	S	71.09	3,800	270,142	171,200	175 K to 171.2 K (-2.17 %)
Jan 04 2021	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Grant	A	0.00	800,000	0	3,344,022	2.5 M to 3.3 M (+31.45 %)
Jan 04 2021	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Gift	G	0.00	599	0	2,544,022	2.5 M to 2.5 M (-0.02 %)
Dec 30 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Gift	G	0.00	1,126	0	2,544,621	2.5 M to 2.5 M (-0.04 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	35	0	113,868	113.9 K to 113.9 K (-0.03 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	35	0	113,903	113.9 K to 113.9 K (-0.03 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	200	0	113,938	114.1 K to 113.9 K (-0.18 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	35	0	114,138	114.2 K to 114.1 K (-0.03 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	35	0	114,173	114.2 K to 114.2 K (-0.03 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	200	0	114,208	114.4 K to 114.2 K (-0.17 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	200	0	114,408	114.6 K to 114.4 K (-0.17 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	65	0	114,608	114.7 K to 114.6 K (-0.06 %)
Dec 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	65	0	114,673	114.7 K to 114.7 K (-0.06 %)
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	6.15	28,274	173,885	800,033
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	4.75	12,236	58,121	828,307
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	6.15	28,274	173,885	2,545,747	2.5 M to 2.5 M (+1.12 %)
Dec 22 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	4.75	12,236	58,121	2,517,473	2.5 M to 2.5 M (+0.49 %)
Dec 18 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	79.59	500	39,795	15,000	15.5 K to 15 K (-3.23 %)
Dec 18 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	79.30	9,075	719,648	114,738	123.8 K to 114.7 K (-7.33 %)
Dec 18 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	15,500	0	15,500	0 to 15.5 K
Dec 18 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	15,500	0	15,500	0 to 15.5 K
Dec 18 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	31,000	0	123,813	154.8 K to 123.8 K (-20.02 %)
Dec 11 2020	ARWR	ARROWHEAD PHARMACE ...	Waddill William D.	Director	Sell	S	73.10	1,800	131,580	25,000	26.8 K to 25 K (-6.72 %)
Dec 11 2020	ARWR	ARROWHEAD PHARMACE ...	Waddill William D.	Director	Sell	S	68.50	1,200	82,200	26,800	28 K to 26.8 K (-4.29 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	2.01	38,676	77,739	840,543
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	2.01	16,324	32,811	879,219
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	71.61	4,003	286,655	2,505,237	2.5 M to 2.5 M (-0.16 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	70.87	5,880	416,716	2,509,240	2.5 M to 2.5 M (-0.23 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	69.80	12,067	842,277	2,515,120	2.5 M to 2.5 M (-0.48 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.27	16,726	1,125,158	2,527,187	2.5 M to 2.5 M (-0.66 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	2.01	38,676	77,739	2,543,913	2.5 M to 2.5 M (+1.54 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	67.97	16,324	1,109,542	2,505,237	2.5 M to 2.5 M (-0.65 %)
Dec 10 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	2.01	16,324	32,811	2,521,561	2.5 M to 2.5 M (+0.65 %)
Nov 23 2020	ARWR	ARROWHEAD PHARMACE ...	Bradshaw Curt	Chief Scientific Of ...	Sell	S	68.73	15,625	1,073,906	0	15.6 K to 0 (-100.00 %)
Nov 23 2020	ARWR	ARROWHEAD PHARMACE ...	Bradshaw Curt	Chief Scientific Of ...	Sell	S	69.39	15,625	1,084,219	15,625	31.3 K to 15.6 K (-50.00 %)
Nov 20 2020	ARWR	ARROWHEAD PHARMACE ...	San Martin Javier	Chief Medical Offic ...	Sell	S	69.39	19,500	1,353,105	130,500	150 K to 130.5 K (-13.00 %)
Nov 12 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	14.54	43,505	632,563	0
Nov 12 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	69.86	17,665	1,234,077	427,668	445.3 K to 427.7 K (-3.97 %)
Nov 12 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	69.04	25,840	1,783,994	445,333	471.2 K to 445.3 K (-5.48 %)
Nov 12 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	14.54	43,505	632,563	471,173	427.7 K to 471.2 K (+10.17 %)
Oct 26 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	50.00	500	25,000	17,500	17 K to 17.5 K (+2.94 %)
Oct 26 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	50.93	500	25,465	17,000	16.5 K to 17 K (+3.03 %)
Oct 22 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	6.15	29,166	179,371	43,505
Oct 22 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Sell	S	54.04	29,166	1,576,131	427,668	456.8 K to 427.7 K (-6.38 %)
Oct 22 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	6.15	29,166	179,371	456,834	427.7 K to 456.8 K (+6.82 %)
Oct 13 2020	ARWR	ARROWHEAD PHARMACE ...	Ferrari Mauro	Director	Sell	S	48.00	10,000	480,000	30,971	41 K to 31 K (-24.41 %)
Aug 14 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Option Exercise	M	9.90	50,000	495,000	895,543
Aug 14 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	41.35	50,000	2,067,500	2,605,237	2.7 M to 2.6 M (-1.88 %)
Aug 14 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Buy	M	9.90	50,000	495,000	2,655,237	2.6 M to 2.7 M (+1.92 %)
Jun 26 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	39.55	23	910	2,605,237	2.6 M to 2.6 M (0.00 %)
Jun 26 2020	ARWR	ARROWHEAD PHARMACE ...	Anzalone Christopher Richard	Chief Executive Off ...	Sell	S	38.81	99,977	3,880,107	2,605,260	2.7 M to 2.6 M (-3.70 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	31.33	500	15,665	16,500	16 K to 16.5 K (+3.13 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	35.40	500	17,700	16,000	15.5 K to 16 K (+3.23 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	23.94	500	11,970	15,500	15 K to 15.5 K (+3.33 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	24.80	500	12,400	15,000	14.5 K to 15 K (+3.45 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	28.60	500	14,300	14,500	14 K to 14.5 K (+3.57 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	34.39	500	17,195	14,000	13.5 K to 14 K (+3.70 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	35.07	500	17,535	13,500	13 K to 13.5 K (+3.85 %)
Jun 24 2020	ARWR	ARROWHEAD PHARMACE ...	De Backer Marianne	Director	Buy	P	54.95	500	27,475	13,000	12.5 K to 13 K (+4.00 %)
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Option Exercise	M	4.20	25,000	105,000	0
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Option Exercise	M	5.19	15,000	77,850	25,000
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Option Exercise	M	2.62	10,000	26,200	40,000
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Option Exercise	M	2.19	15,000	32,850	50,000
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Option Exercise	M	2.01	5,000	10,050	65,000
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Option Exercise	M	4.75	7,000	33,250	70,000
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Buy	M	4.20	25,000	105,000	85,000	60 K to 85 K (+41.67 %)
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Buy	M	5.19	15,000	77,850	60,000	45 K to 60 K (+33.33 %)
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Buy	M	2.62	10,000	26,200	45,000	35 K to 45 K (+28.57 %)
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Buy	M	2.19	15,000	32,850	35,000	20 K to 35 K (+75.00 %)
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Buy	M	2.01	5,000	10,050	20,000	15 K to 20 K (+33.33 %)
May 18 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Buy	M	4.75	7,000	33,250	15,000	8 K to 15 K (+87.50 %)
May 13 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Sell	S	36.42	6,100	222,162	8,000	14.1 K to 8 K (-43.26 %)
May 13 2020	ARWR	ARROWHEAD PHARMACE ...	PERRY MICHAEL S	Director	Sell	S	35.71	29,900	1,067,729	14,100	44 K to 14.1 K (-67.95 %)
May 13 2020	ARWR	ARROWHEAD PHARMACE ...	Waddill William D.	Director	Sell	S	36.54	26,000	950,040	28,000	54 K to 28 K (-48.15 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	5.20	213	1,108	329,347
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	5.19	830	4,308	329,560
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	4.75	1,200	5,700	330,390
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	14.54	1,454	21,141	331,590
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	7.75	500	3,875	333,044
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	5.19	200	1,038	333,544
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	700	28,000	850,730	851.4 K to 850.7 K (-0.08 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	204	8,160	851,430	851.6 K to 851.4 K (-0.02 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	213	8,520	851,634	851.8 K to 851.6 K (-0.03 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	830	33,200	851,847	852.7 K to 851.8 K (-0.10 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	1,200	48,000	852,677	853.9 K to 852.7 K (-0.14 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	1,454	58,160	853,877	855.3 K to 853.9 K (-0.17 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	500	20,000	855,331	855.8 K to 855.3 K (-0.06 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	5.20	213	1,108	855,831	855.6 K to 855.8 K (+0.02 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	5.19	830	4,308	855,618	854.8 K to 855.6 K (+0.10 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	4.75	1,200	5,700	854,788	853.6 K to 854.8 K (+0.14 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	14.54	1,454	21,141	853,588	852.1 K to 853.6 K (+0.17 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	7.75	500	3,875	852,134	851.6 K to 852.1 K (+0.06 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	100	4,000	851,634	851.7 K to 851.6 K (-0.01 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	200	8,000	851,734	851.9 K to 851.7 K (-0.02 %)
Apr 29 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	5.19	200	1,038	851,934	851.7 K to 851.9 K (+0.02 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	14.54	5,300	77,062	333,744
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	5.20	3,456	17,971	339,044
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	5.19	3,700	19,203	342,500
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Option Exercise	M	4.75	3,800	18,050	346,200
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	3,805	152,200	851,734	855.5 K to 851.7 K (-0.44 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	3,454	138,160	855,539	859 K to 855.5 K (-0.40 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	5,300	212,000	858,993	864.3 K to 859 K (-0.61 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	3,456	138,240	864,293	867.7 K to 864.3 K (-0.40 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	3,700	148,000	867,749	871.4 K to 867.7 K (-0.42 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Sell	S	40.00	3,800	152,000	871,449	875.2 K to 871.4 K (-0.43 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	14.54	5,300	77,062	875,249	869.9 K to 875.2 K (+0.61 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	5.20	3,456	17,971	869,949	866.5 K to 869.9 K (+0.40 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	5.19	3,700	19,203	866,493	862.8 K to 866.5 K (+0.43 %)
Apr 22 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN BRUCE D	Chief Operating Off ...	Buy	M	4.75	3,800	18,050	862,793	859 K to 862.8 K (+0.44 %)
Apr 16 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	1,112	0	154,813	155.9 K to 154.8 K (-0.71 %)
Apr 16 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	36.89	25,000	922,250	155,925	180.9 K to 155.9 K (-13.82 %)
Apr 16 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Gift	G	0.00	1,112	0	154,813	155.9 K to 154.8 K (-0.71 %)
Apr 16 2020	ARWR	ARROWHEAD PHARMACE ...	GIVEN DOUGLAS B	Director	Sell	S	36.89	25,000	922,250	155,925	180.9 K to 155.9 K (-13.82 %)
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	6.15	10,834	66,629	72,671
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	7.75	12,116	93,899	83,505
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	14.54	6,495	94,437	95,621
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	5.19	2,000	10,380	102,116
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Option Exercise	M	9.90	12,000	118,800	104,116
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	6.15	10,834	66,629	427,668	416.8 K to 427.7 K (+2.60 %)
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	7.75	12,116	93,899	416,834	404.7 K to 416.8 K (+2.99 %)
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	14.54	6,495	94,437	404,718	398.2 K to 404.7 K (+1.63 %)
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	5.19	2,000	10,380	398,223	396.2 K to 398.2 K (+0.50 %)
Feb 27 2020	ARWR	ARROWHEAD PHARMACE ...	Myszkowski Kenneth Allen	Chief Financial Off ...	Buy	M	9.90	12,000	118,800	396,223	384.2 K to 396.2 K (+3.12 %)
Feb 19 2020	ARWR	ARROWHEAD PHARMACE ...	Ferrari Mauro	Director	Grant	A	0.00	26,571	0	40,971	14.4 K to 41 K (+184.52 %)

Page: 1 2 3 4 5 ... 5 next >